Oxylabs filed antitrust counterclaims against Luminati (Luminati Networks Ltd.), and claims against Luminati’s investor EMK Capital LLP and Hola (Hola VPN Ltd. and Hola Networks Ltd.).
The claims asserted by Oxylabs include: violation and conspiracy to violate the antitrust laws of the United States, monopolization and attempted monopolization of the residential proxy marketplace, and the filing of sham patent-infringement lawsuits against competitors.
To promote fair marketplace practices, Oxylabs seek to redress the injuries it has suffered and hold Luminati, EMK Capital, and Hola accountable for their actions.
These antitrust counterclaims and claims are a continuation of Oxylabs’ defensive actions and follow the March 5, 2020 lawsuit Oxylabs filed against Luminati and EMK Capital LLP. In that lawsuit, Oxylabs asserted the following claims: unfair competition, false advertising, false patent marking, defamation/business disparagement, tortious interference with prospective business relations, tortious interference with the existing contract, breach of contract, and conspiracy.
Oxylabs will not be intimidated by what we believe are unfair business practices by Luminati, EMK Capital LLP and Hola, and Oxylabs will continue to develop its business successfully. Furthermore, the company will continue to protect its technology and reputation utilizing all available legal remedies.
Finally, Oxylabs will always strive to ensure a fair market in which innovation thrives through legitimate competition, delivering increasingly better products and as much value as possible for its clients.